Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasem Al-Hashel

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
JAMA Neurology|May 31, 2017
Confusing Terminology-Neuroleptic Malignant Syndrome vs Malignant Hyperthermia-ReplyPhilippe Damier, Jasem Al-Hashel
JAMA Neurology|December 28, 2016
Recommendations for the Treatment of Patients With Parkinson Disease During RamadanPhilippe Damier, Jasem Al-Hashel
Case Reports in Neurology|April 18, 2022
Late-Onset Pompe Disease Presenting with Isolated Tongue InvolvementJasem Al-Hashel, Ismail Ismail
Multiple Sclerosis and Related Disorders|February 2, 2025
Effectiveness of 6-week dosing of Natalizumab versus continued 4-week treatment for Multiple Sclerosis: An observational registry-based studyRaed Alroughani, Jasem Al-Hashel, Samar Farouk Ahmed
Pediatric Neurology|September 19, 2015
Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective AnalysisRaed Alroughani, Samar F Ahmed, Jasem Al-Hashel
Clinical Neurology and Neurosurgery|March 21, 2024
Substantial and comparable suppression of disease activity following early initiation of cladribine tablets, ocrelizumab or alemtuzumab as first pharmacologic treatment for relapsing multiple sclerosis: A real world studyRaed Alroughani, Jasem Al-Hashel, Samar Farouk Ahmed
Neuroepidemiology|August 22, 2008
The prevalence of multiple sclerosis in the Middle EastJasem Al-Hashel, Aaron D Besterman, Christina Wolfson
Multiple Sclerosis and Related Disorders|February 8, 2018
A longitudinal study of JC virus serostatus stability among multiple sclerosis patientsRaed Alroughani, Saeed Akhtar, Samar Ahmed, et al.
Case Reports in Neurological Medicine|May 14, 2014
An adult patient with ocular myasthenia and unusually long spontaneous remissionJasem Al-Hashel, Hanaa M Rashad, Rossen T Rousseff
Multiple Sclerosis and Related Disorders|August 26, 2023
Real world study of ocrelizumab in multiple sclerosis: Kuwait experienceRaed Alroughani, Malak AlMojel, Jasem Al-Hashel, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
JAMA Neurology|May 31, 2017
Confusing Terminology-Neuroleptic Malignant Syndrome vs Malignant Hyperthermia-ReplyPhilippe Damier, Jasem Al-Hashel
JAMA Neurology|December 28, 2016
Recommendations for the Treatment of Patients With Parkinson Disease During RamadanPhilippe Damier, Jasem Al-Hashel
Case Reports in Neurology|April 18, 2022
Late-Onset Pompe Disease Presenting with Isolated Tongue InvolvementJasem Al-Hashel, Ismail Ismail
Multiple Sclerosis and Related Disorders|February 2, 2025
Effectiveness of 6-week dosing of Natalizumab versus continued 4-week treatment for Multiple Sclerosis: An observational registry-based studyRaed Alroughani, Jasem Al-Hashel, Samar Farouk Ahmed
Pediatric Neurology|September 19, 2015
Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective AnalysisRaed Alroughani, Samar F Ahmed, Jasem Al-Hashel
Clinical Neurology and Neurosurgery|March 21, 2024
Substantial and comparable suppression of disease activity following early initiation of cladribine tablets, ocrelizumab or alemtuzumab as first pharmacologic treatment for relapsing multiple sclerosis: A real world studyRaed Alroughani, Jasem Al-Hashel, Samar Farouk Ahmed
Neuroepidemiology|August 22, 2008
The prevalence of multiple sclerosis in the Middle EastJasem Al-Hashel, Aaron D Besterman, Christina Wolfson
Multiple Sclerosis and Related Disorders|February 8, 2018
A longitudinal study of JC virus serostatus stability among multiple sclerosis patientsRaed Alroughani, Saeed Akhtar, Samar Ahmed, et al.
Case Reports in Neurological Medicine|May 14, 2014
An adult patient with ocular myasthenia and unusually long spontaneous remissionJasem Al-Hashel, Hanaa M Rashad, Rossen T Rousseff
Multiple Sclerosis and Related Disorders|August 26, 2023
Real world study of ocrelizumab in multiple sclerosis: Kuwait experienceRaed Alroughani, Malak AlMojel, Jasem Al-Hashel, et al.
Pageof 5